These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1407433)

  • 1. Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes.
    Holladay FP; Heitz T; Chen YL; Chiga M; Wood GW
    Neurosurgery; 1992 Sep; 31(3):528-33. PubMed ID: 1407433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
    Holladay FP; Heitz T; Wood GW
    J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
    Holladay FP; Lopez G; De M; Morantz RA; Wood GW
    Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cellular immune responses against a glioma-associated antigen(s).
    Holladay FP; Wood GW
    J Neuroimmunol; 1993 Apr; 44(1):27-32. PubMed ID: 8496337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
    Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic immune responses during the progression of a rat glioma.
    Holladay FP; Choudhuri R; Heitz T; Wood GW
    J Neurosurg; 1994 Jan; 80(1):90-6. PubMed ID: 8271027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T-cell mediated anti-tumor responses cross-reacting against 9L and RT2 rat glioma cell lines.
    Shah MR; Ramsey WJ
    Cell Immunol; 2003 Oct; 225(2):113-21. PubMed ID: 14698145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
    Zhu X; Lu C; Xiao B; Qiao J; Sun Y
    J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental approach to specific adoptive immunotherapy for malignant brain tumors.
    Yamasaki T; Kikuchi H
    Nihon Geka Hokan; 1989 Nov; 58(6):485-92. PubMed ID: 2519184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
    Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
    J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.
    Baldwin NG; Rice CD; Tuttle TM; Bear HD; Hirsch JI; Merchant RE
    J Neurooncol; 1997 Mar; 32(1):19-28. PubMed ID: 9049859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12-based immunotherapy against rat 9L glioma.
    Jean WC; Spellman SR; Wallenfriedman MA; Hall WA; Low WC
    Neurosurgery; 1998 Apr; 42(4):850-6; discussion 856-7. PubMed ID: 9574650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
    Jeffes EW; Zhang JG; Hoa N; Petkar A; Delgado C; Chong S; Obenaus A; Sanchez R; Khalaghizadeh S; Khomenko T; Knight BA; Alipanah R; Nguyen TV; Shah C; Vohra S; Zhuang JL; Liu J; Wepsic HT; Jadus MR
    J Immunol; 2005 Mar; 174(5):2533-43. PubMed ID: 15728459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.
    Parsa AT; Chakrabarti I; Hurley PT; Chi JH; Hall JS; Kaiser MG; Bruce JN
    Neurosurgery; 2000 Oct; 47(4):993-9; discussion 999-1000. PubMed ID: 11014444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer efficacy of allogeneic vaccine modified with progenitor neural cells supernatant in rats with glioma 101.8.
    Liubich LD; Lisyany MI
    Exp Oncol; 2015 Sep; 37(3):203-7. PubMed ID: 26422105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.
    Machein MR; Risau W; Plate KH
    Hum Gene Ther; 1999 May; 10(7):1117-28. PubMed ID: 10340544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
    Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
    Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THE INFLUENCE OF PROGENITOR NEURO- CELLS SUPERNATANT ON THE LYMPHO- CYTES CYTOTOXIC FUNCTION IN RATS WITH GLIOMA].
    Liubich LD; Lisyany NI
    Fiziol Zh (1994); 2015; 61(4):63-70. PubMed ID: 26552307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas.
    Mariani CL; Rajon D; Bova FJ; Streit WJ
    J Neurooncol; 2007 Dec; 85(3):231-40. PubMed ID: 17568998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.